|

Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue

RECRUITINGN/ASponsored by University of Michigan
Actively Recruiting
PhaseN/A
SponsorUniversity of Michigan
Started2018-01-02
Est. completion2026-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT02584270

Summary

This study will fill a scientific gap in the current knowledge providing data for evaluation of the palatal augmentation prosthesis (PAP) as a therapeutic modality post-surgery. This is a robust scientific randomized prospective clinical trial. Positive outcomes from this study have the potential to dramatically alter the most common issues of oral cancer therapy, namely speech and swallowing functions. Patients will have been diagnosed with a cancer lesion of the tongue requiring surgery and removal of part of the tongue. Smaller cancers of the tongue are sized as T1 or T2. For patients with smaller lesions, a PAP, which can aid in speaking and swallowing, is not routinely provided.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients with a new diagnosis of a T1/T2 tongue cancer

Exclusion Criteria:

* Patients with recurrent disease
* Patients with a history of prior head and neck radiation therapy
* Patients who lack adequate maxillary dentition to support a palatal augmentation prosthesis

Conditions4

CancerOral CancerTongue CancerTongue Neoplasms

Locations1 site

University of Michigan Department of Oral and Maxillofacial Surgery and Hospital Dentistry
Ann Arbor, Michigan, 48109
Stephanie Munz, DDS734-936-8289smmunz@med.umich.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.